Cedelizumab

Cedelizumab
Monoclonal antibody
Type Whole antibody
Source Humanized (from mouse)
Target CD4
Identifiers
CAS Number 156586-90-2 N
ATC code None
ChemSpider none
KEGG D03420 YesY
 NYesY (what is this?)  (verify)

Cedelizumab is a monoclonal antibody acting on the immune system.[1] Possible indications include the prevention of organ transplant rejections and the treatment of autoimmune diseases.[2]

References

  1. WHO Drug Information
  2. The NDA pipeline. F-D-C Development Corporation. 2001.


This article is issued from Wikipedia - version of the Thursday, November 19, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.